Evidence map›Paper›PMID 35985974›Full record

ReviewJournal of integrative medicine2022

Potential medicinal plants involved in inhibiting 3CL

Fan Yang, Xiao-Lan Jiang, Akash Tariq, Sehrish Sadia, Zeeshan Ahmed, Jordi Sardans, Muhammad Aleem, Riaz Ullah, Rainer W Bussmann

Open access · greenAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of integrative medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Computational andFrontiers in pharmacology · 2025
    Article
  4. Article
  5. Review
  6. Heliyon · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 5 countries.

Fan YangThe Medical Center of General Practice, Sichuan Academy of Medical Science and Sichuan Provincial People's Hospital, Chengdu 610041, Sichuan Province, China.
Xiao-Lan JiangThe Medical Center of General Practice, Sichuan Academy of Medical Science and Sichuan Provincial People's Hospital, Chengdu 610041, Sichuan Province, China. Electronic address: jxlljy2011@163.com.
Akash TariqXinjiang Institute of Ecology and Geography, Chinese Academy of Sciences, Urumqi 830041, Xinjiang Uygur Autonomous Region, China. Electronic address: akash.malik786@mails.ucas.ac.cn.
Sehrish SadiaDepartment of Biological Sciences, University of Veterinary and Animal Sciences, Ravi Campus, Pattoki 55300, Pakistan.
Zeeshan AhmedXinjiang Institute of Ecology and Geography, Chinese Academy of Sciences, Urumqi 830041, Xinjiang Uygur Autonomous Region, China.
Jordi SardansConsejo Superior de Investigaciones Científicas, Global Ecology Unit, Centre for Ecological Research and Forestry Applications-Consejo Superior de Investigaciones Científicas-Universitat Autònoma de Barcelona, Bellaterra, Barcelona 08193, Catalonia, Spain; Centre for Ecological Research and Forestry Applications, Cerdanyola del Vallès 08193, Catalonia, Spain.
Muhammad AleemDepartment of Biological Sciences, University of Veterinary and Animal Sciences, Ravi Campus, Pattoki 55300, Pakistan.
Riaz UllahDepartment of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
Rainer W BussmannDepartment of Ethnobotany, Institute of Botany, llia State University, Tbilisi 0105, Georgia.
Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital · CNUniversity of Veterinary and Animal Sciences · PKCentre for Research on Ecology and Forestry Applications · ESChinese Academy of Sciences · CNIlia State University · GEKing Saud University · SAXinjiang Institute of Ecology and Geography · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

At present, a variety of vaccines have been approved, and existing antiviral drugs are being tested to find an effective treatment for coronavirus disease 2019 (COVID-19). However, no standardized treatment has yet been approved by the World Health Organization. The virally encoded chymotrypsin-like protease (3CL

Indexed as

COVID-19 Drug TreatmentPlants, MedicinalFuransPentacyclic TriterpenesPhenanthrenesQuinonesSARS-CoV-2celastrol methyl esterdihydrotanshinone IFuransPentacyclic TriterpenesPhenanthrenesQuinonesCoronavirus 3C proteasesCOVID-19Drug developmentMedicinal plantsPlant-derived compoundsSARS-CoV-2

Identifiers

PMID35985974
PMCPMC9359926
OpenAlexW4293004039

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.